Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

QTRX
Quanterix Corporation Common Stock
stock NASDAQ

Market Open
Aug 10, 2026 3:15:05 PM EDT
2.43USD-39.702%(-1.60)3,579,038
2.43Bid   2.44Ask   0.01Spread
Pre-market
Aug 10, 2026 9:29:30 AM EDT
2.31USD-42.680%(-1.72)263,184
After-hours
Aug 7, 2026 4:00:30 PM EDT
4.03USD0.000%(0.00)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 26, 2022
11:30AM EST  Quanterix' Simoa(r) Technology Powers Latest Breakthrough in Epstein-Barr Virus and Multiple Sclerosis   Business Wire
Jan 13, 2022
11:45AM EST  Quanterix Sees Q4 Sales $29M-$31M Vs. $27.08M Est., FY21 Sales $109M-$111M Vs. $105.54M Est.   Benzinga
07:30AM EST  Quanterix Provides Operational and Preliminary Financial Highlights   Business Wire
Jan 6, 2022
04:30PM EST  Quanterix to Present at 40th Annual J.P. Morgan Healthcare Conference   Business Wire
Nov 17, 2021
04:15PM EST  Quanterix Recognized as a Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500(tm)   Business Wire
Nov 16, 2021
09:22AM EST  Quanterix' Simoa Technology Powers Advances In Alzheimer's Disease Research Presented At 2021 Clinical Trials On Alzheimer's Disease (CTAD) Conference   Benzinga
Nov 11, 2021
04:30PM EST  Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum   Business Wire
Nov 8, 2021
01:21PM EST  Quanterix Co-Inventor of Simoa(r) David Walt Receives Kabiller Prize in Nanoscience and Nanomedicine   Business Wire
Nov 5, 2021
09:23AM EDT  Quanterix Q3 Sales $26.70M Beat $24.01M Estimate   Benzinga
Nov 4, 2021
04:01PM EDT  Quanterix Corporation Releases Operating Results for Third Quarter of 2021   Business Wire
05:00AM EDT  Earnings Scheduled For November 4, 2021   Benzinga
Oct 28, 2021
04:30PM EDT  Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021   Business Wire
Oct 12, 2021
05:47AM EDT  The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 5.30 A.M. EDT).   RTTNews
05:18AM EDT  Quanterix Shares Rise 16% Premarket; Co Announced Monday it Was Granted Breakthrough Device Designation from the FDA for Blood-Based pTau-181 Assay For Alzheimer's Disease   Benzinga
Oct 11, 2021
04:06PM EDT  Quanterix Granted Breakthrough Device Designation From U.S. FDA for Blood-Based pTau-181 Assay For Alzheimer's Disease   Benzinga
Sep 20, 2021
08:26AM EDT  Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories   Business Wire
Sep 14, 2021
07:40AM EDT  FDA Expands Quanterix's COVID-19 Antigen Test Emergency Use Label   Benzinga
Sep 13, 2021
05:42PM EDT  Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test   Business Wire
Sep 10, 2021
05:28PM EDT  Quanterix to Host Webinar with Leading Pathologist from Emory Medical Laboratories: "COVID-19 Testing in a Residential University Setting: Implementation, Insights, and Learnings"   Business Wire
Sep 3, 2021
10:50AM EDT  Return On Capital Employed Insights For Quanterix   Benzinga
Aug 27, 2021
09:19AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Friday, Aug. 27, 2021: BABA, ZM, SAVA, SPRT, CHGG   Benzinga
08:27AM EDT  Quanterix Says Did Not Interpret Test Results Or Prepare Data Charts Presented By Cassava At AAIC In July 2021   RTTNews
08:22AM EDT  Quanterix In Statement Following Cassava Reports Says 'Quanterix or its employees did not interpret the test results or prepare the data charts presented by Cassava at the Alzheimer's Association International Conference (AAIC) in July 2021 or otherwise.'   Benzinga
08:19AM EDT  Quanterix Releases Statement   Business Wire
Aug 9, 2021
04:30PM EDT  Quanterix to Participate in the Canaccord Genuity 41st Annual Growth Conference   Business Wire
Aug 6, 2021
08:03AM EDT  Quanterix SimoaTechnology Powers Breakthrough Alzheimer's Disease Research Presented By Lilly At AAIC   RTTNews
07:58AM EDT  Quanterix Highlights Eli Lilly's Presentation Of Phase 2 TRAILBLAZER-ALZ Study Utilizing Quanterix' Simoa HD-X   Benzinga
07:57AM EDT  Quanterix Simoa(r) Technology Powers Breakthrough Alzheimer's Disease Research Presented by Eli Lilly and Company at Alzheimer's Association International Conference (AAIC) 2021   Business Wire
Aug 5, 2021
06:09PM EDT  Quanterix Q2 Non-GAAP Loss $12.94M Down From $11.61M YoY   Benzinga
04:18PM EDT  Quanterix Corporation Releases Operating Results for Second Quarter of 2021   Business Wire
10:34AM EDT  Canaccord Genuity Maintains Buy on Quanterix, Lowers Price Target to $75   Benzinga
04:08AM EDT  Earnings Scheduled For August 5, 2021   Benzinga
Jul 28, 2021
07:04AM EDT  Quanterix Corporation to Release Second Quarter 2021 Financial Results on Aug. 5, 2021   Business Wire
Jun 28, 2021
04:12PM EDT  Quanterix Appoints Michael Doyle As CFO   RTTNews
04:12PM EDT  Quanterix Names Michael Doyle CFO   Benzinga
04:08PM EDT  Quanterix Appoints Michael Doyle As Chief Financial Officer   Benzinga
Jun 7, 2021
10:13AM EDT  Quanterix' Simoa Technology Powers Largest and Most Diverse Global Investigation of Plasma Neurofilament Light's Role in Dementia Diagnosis   Business Wire
Jun 4, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For June 4, 2021   Benzinga
06:29AM EDT  Goldman Sachs Initiates Coverage On Quanterix with Sell Rating, Announces Price Target of $53   Benzinga
Jun 2, 2021
11:02AM EDT  Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report   Business Wire
May 11, 2021
08:00AM EDT  Quanterix Appoints Masoud Toloue as President of Quanterix and Diagnostics   Business Wire
May 6, 2021
08:15AM EDT  SVB Leerink Maintains Outperform on Quanterix, Lowers Price Target to $70   Benzinga
May 5, 2021
04:22PM EDT  Quanterix Q1 Sales $24.90M Beat $21.36M Estimate   Benzinga
04:01PM EDT  Quanterix Corporation Releases Operating Results for First Quarter 2021   Business Wire
04:16AM EDT  Earnings Scheduled For May 5, 2021   Benzinga
Apr 28, 2021
04:30PM EDT  Quanterix Corporation to Release First Quarter 2021 Financial Results on May 5, 2021   Business Wire
07:47AM EDT  Quanterix Appoints Laurie Olson To Board   RTTNews
07:30AM EDT  Quanterix Appoints Laurie Olson to Board of Directors   Business Wire
Apr 22, 2021
03:29PM EDT  Quanterix Webinar: Recent Advancements in Neurodegenerative Biomarkers: Progress Towards A Diagnostic Blood Test for Alzheimer's Disease   Business Wire
Apr 21, 2021
07:18AM EDT  Quanterix Names Shawn Stetson As Interim CFO, Effective May 11, 2021   RTTNews
07:12AM EDT  Quanterix Announces Appointment Of Shawn Stetson As Interim Chief Financial Officer   Benzinga
07:10AM EDT  Quanterix Announces Appointment of Interim Chief Financial Officer   Business Wire
Apr 20, 2021
04:37PM EDT  Quanterix Corp Says On April 14, Amol Chaubal Notified Co. Of His Resignation As CFO And Treasurer, Effective May 11   Benzinga
Mar 26, 2021
06:55AM EDT  Simoa Demonstrates Advancements In COVID-19 Research Thro Viral Antigen Measurements In Blood, Saliva Samples   RTTNews
06:48AM EDT  Quanterix Reports Its Simoa Technology Showed Advancements In COVID-19 Research Through Viral Antigen Measurements In Blood, Saliva Samples   Benzinga
06:47AM EDT  Quanterix' Simoa Technology Demonstrates Advancements in COVID-19 Research through Viral Antigen Measurements in Blood and Saliva Samples   Business Wire
Mar 17, 2021
04:01PM EDT  Quanterix' Simoa Technology Accelerates Critical Plasma Biomarker Research Presented at the 15th International Conference on Parkinson's & Alzheimer's Disease (AD/PDTM 2021)   Business Wire
Mar 3, 2021
05:08AM EST  SVB Leerink Maintains Outperform on Quanterix, Raises Price Target to $85   Benzinga
Mar 2, 2021
04:07PM EST  Quanterix Q4 Adj. Loss From Operations $11.651M vs $10.799M In Same Qtr. Last Year, Sales $21.60M Miss $23.44M Estimate   Benzinga
04:03PM EST  Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2020   Business Wire
03:40AM EST  Earnings Scheduled For March 2, 2021   Benzinga
Mar 1, 2021
10:05AM EST  Preview: Quanterix's Earnings   Benzinga
Feb 25, 2021
06:05PM EST  Quanterix' Kevin Hrusovsky to Present at the Cowen 41st Annual Health Care Conference on March 3 and Appear on the Feb. 26 Episode of the Health Care Rounds Podcast   Business Wire
Feb 23, 2021
11:19AM EST  Quanterix Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021   Business Wire
Feb 18, 2021
11:59AM EST  Quanterix to Present at the 10th Annual SVB Leerink Global Healthcare Conference   Business Wire
Feb 12, 2021
02:09PM EST  Quanterix to Open a Joint Lab with WuXi App Tec to Serve the Chinese Market   Benzinga
02:08PM EST  Quanterix Announces Simoa(r) Joint Laboratory with WuXi AppTec   Business Wire
Feb 8, 2021
03:12PM EST  Quanterix Announces Closing of Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares   Business Wire
Feb 4, 2021
09:59AM EST  Quanterix shares were trading lower after the company priced its 3.57 million shares common stock offering at $70 per share.   Benzinga
07:06AM EST  Quanterix Prices ~3.57M Share Offering At $70/Share   Benzinga
07:00AM EST  Quanterix Prices Public Offering of Common Stock   Business Wire
Feb 3, 2021
04:25PM EST  Quanterix Reports $200M Common Stock Offering   Benzinga
04:25PM EST  Quanterix Announces Proposed Public Offering of $200.0 Million of its Common Stock   Business Wire
Jan 27, 2021
05:27AM EST  SVB Leerink Maintains Outperform on Quanterix, Raises Price Target to $75   Benzinga
Jan 22, 2021
03:39PM EST  Quanterix to Participate in PMWC 2021 COVID-19 Conference   Business Wire
Jan 13, 2021
08:39AM EST  Quanterix Expects Q4 GAAP Revenue Of $24 Mln-$26 Mln; Non-GAAP Revenue Of $20 Mln -$22 Mln   RTTNews
08:37AM EST  Quanterix Sees Q4 Sales $20M-$22M vs $21.7M Estimate   Benzinga
08:30AM EST  Quanterix Provides Operational and Preliminary Financial Highlights   Business Wire
Jan 11, 2021
04:31PM EST  Quanterix Receives FDA Emergency Use Authorization For SARS-CoV-2 N Protein Antigen Test   Benzinga
Jan 6, 2021
04:06PM EST  Quanterix Corporation to Present At 39th Annual J.P. Morgan Healthcare Conference   Business Wire
Dec 28, 2020
09:32PM EST  The U.S. Food and Drug Administration has authorized the emergency use of Quanterix Corp.'s (QTRX) Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test. The test could be run on the Simoa HD-X Analyzer, a fully automated high-throughput immunoassay instrument.   RTTNews
06:46PM EST  Quanterix Receives FDA Emergency Use Authorization for Semi-Quantitative Antibody Test   Business Wire
Dec 9, 2020
09:00AM EST  Quanterix to Participate in Contagion Conference   Business Wire
Nov 18, 2020
04:32PM EST  Quanterix Appoints William Geist As COO   RTTNews
04:28PM EST  Quanterix Appoints William Geist As Chief Operating Officer   Benzinga
Nov 13, 2020
12:36PM EST  Quanterix to Participate in the Canaccord Medical Technologies and Diagnostics Forum   Business Wire
Nov 6, 2020
04:20AM EST  SVB Leerink Maintains Outperform on Quanterix, Raises Price Target to $50   Benzinga
Nov 5, 2020
05:47PM EST  Quanterix Q3 Sales $31.39M Beat $14.91M Estimate   Benzinga
04:17PM EST  Quanterix Corporation Releases Operating Results for Third Quarter 2020   Business Wire
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Oct 30, 2020
05:33PM EDT  908 Devices Names Kevin Hrusovsky, 30-year Biotechnology Veteran and Founder of   PR Newswire
Oct 29, 2020
02:40PM EDT  Quanterix Corporation to Release Third Quarter 2020 Financial Results on November 5, 2020   Business Wire
Oct 28, 2020
11:37AM EDT  Kevin Hrusovsky to Speak at Precision Medicine Leaders Summit's Precision Oncology Conference   Business Wire
Oct 19, 2020
08:25AM EDT  10 Biggest Price Target Changes For Monday   Benzinga
06:24AM EDT  SVB Leerink Maintains Outperform on Quanterix, Raises Price Target to $48   Benzinga
Oct 6, 2020
03:32PM EDT  Quanterix Receives National Institutes of Health RADx Contract to Advance Antigen Test for SARS-CoV-2 (COVID-19)   Business Wire
09:24AM EDT  Canaccord Genuity Maintains Buy on Quanterix, Raises Price Target to $40   Benzinga
Oct 5, 2020
04:01PM EDT  Quanterix Reports License Deal Granting Abbott Access To Portfolio Of Bead-Based Technology Patents For Use In In Vitro Diagnostics   Benzinga
04:01PM EDT  Quanterix Enters into a License Agreement that Grants Abbott Access to Portfolio of Bead-Based Technology Patents for Use in In Vitro Diagnostics   Business Wire
Sep 10, 2020
09:00AM EDT  Quanterix' Simoa Technology Supports 42 Scientific Presentations at MSVirtual2020   Business Wire
Aug 11, 2020
04:34PM EDT  Quanterix Announces Closing of Public Offering Including Exercise in Full of Underwriters' Option to Purchase Additional Shares   Business Wire
09:00AM EDT  Quanterix to Participate in the Canaccord Genuity 40th Annual Growth Conference   Business Wire
Aug 6, 2020
11:03PM EDT  Quanterix Prices Public Offering Of 2.65 Mln Shares At $32.00/shr   RTTNews
10:12PM EDT  Quanterix Prices Public Offering of Common Stock   Business Wire
05:14PM EDT  Quanterix Announces Proposed Public Offering Of Common Stock; Size Not Disclosed   Benzinga
04:11PM EDT  Quanterix Announces Proposed Public Offering of Common Stock   Business Wire
Aug 5, 2020
06:30AM EDT  SVB Leerink Maintains Outperform on Quanterix, Raises Price Target to $37   Benzinga
Aug 4, 2020
04:59PM EDT  Quanterix Q2 Sales $13.10M Down From $13.54M YoY   Benzinga
04:29PM EDT  Quanterix Corporation Releases Operating Results for Second Quarter 2020   Business Wire
Aug 3, 2020
09:08AM EDT  Quanterix Corporation to Release Second Quarter 2020 Financial Results on August 4, 2020   Business Wire
Jul 29, 2020
09:30AM EDT  Quanterix sNfL Assay and Simoa Technology First to Measure Neuronal Injury in COVID-19 Patients' Blood   Business Wire
Jul 27, 2020
07:00AM EDT  Quanterix to Participate in Alzheimer's Association International Conference (AAIC) 2020   Business Wire
Jul 20, 2020
10:49AM EDT  Quanterix' Simoa Technology Powers New Insights Into Coronavirus Immune Response And Reveals Indicators Of Disease Severity   Benzinga
10:41AM EDT  Quanterix' Simoa Technology Powers New Insights into COVID-19 Immune Response and Reveals Indicators of Disease Severity   Business Wire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC